A&E is a specialist medical practice in Genk. Private Limited, started on 3 April 1990, 1 establishment.

What is the address of A&E?

The registered office of A&E is located at Weg naar As 155, 3600 Genk.

Yes. According to the CBE (31 October 2026) A&E is active, legal situation “Normale toestand”, started on 3 April 1990.

Is A&E registered on Peppol?

Yes, A&E is registered on the Peppol network with ID 0208:0440535396.

What is the enterprise number of A&E?

The enterprise number of A&E is BE0440535396.

When was A&E founded?

A&E was founded on 3 April 1990.

Who are the directors of A&E?

According to the 2025 annual accounts, the directors of A&E are: RENÉ HEYLEN, MICHELINE HEYLEN.

Is A&E a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 April 1990; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did A&E make in 2025?

A&E posted a profit after taxes of € 630,513 in financial year 2025.

What is the revenue of A&E?

As a small company, A&E is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 781,629.

How many employees does A&E have?

According to the 2025 annual accounts, A&E has 0 full-time equivalents (FTE).

A&E (Private Limited) - Genk - BE0440535396

Dossier A&E, printed on 31 October 2026 from databakkes.be/en/0440535396/a-e. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

A&E from Genk, company number BE0440535396, closed financial year 2025 with a result of € 630,513 after tax. For that financial year A&E recorded a gross margin of € 781,629 and equity of € 3.6 million. Compared with financial year 2024, the result moved from € 736,423 to € 630,513. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 22, 2026.

What it is worth Healthy

€ 3.6 million

▼ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 630,513

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 158,407

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 750,551 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 8,921

▼ 70% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 32,001

▼ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 168,663

▲ 90% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,111,444 Gross margin 2022: € 1,111,444 First fiscal year in the series	€ 1,093,504 Gross margin 2023: € 1,093,504 ▼ 2% vs 2022 (€ 1,111,444) Unfavourable step	€ 986,977 Gross margin 2024: € 986,977 ▼ 10% vs 2023 (€ 1,093,504) Unfavourable step	€ 781,629 Gross margin 2025: € 781,629 ▼ 21% vs 2024 (€ 986,977) Unfavourable step	▼ 21%
Profit after taxes	€ 742,332 Profit after taxes 2022: € 742,332 First fiscal year in the series	€ 763,465 Profit after taxes 2023: € 763,465 ▲ 3% vs 2022 (€ 742,332) Favourable step	€ 736,423 Profit after taxes 2024: € 736,423 ▼ 4% vs 2023 (€ 763,465) Unfavourable step	€ 630,513 Profit after taxes 2025: € 630,513 ▼ 14% vs 2024 (€ 736,423) Unfavourable step	▼ 14%
Equity	€ 3,401,538 Equity 2022: € 3,401,538 First fiscal year in the series	€ 3,474,614 Equity 2023: € 3,474,614 ▲ 2% vs 2022 (€ 3,401,538) Favourable step	€ 3,763,994 Equity 2024: € 3,763,994 ▲ 8% vs 2023 (€ 3,474,614) Favourable step	€ 3,643,956 Equity 2025: € 3,643,956 ▼ 3% vs 2024 (€ 3,763,994) Unfavourable step	▼ 3%
Total debts	€ 617,052 Total debts 2022: € 617,052 First fiscal year in the series	€ 823,065 Total debts 2023: € 823,065 ▲ 33% vs 2022 (€ 617,052) Unfavourable step	€ 558,067 Total debts 2024: € 558,067 ▼ 32% vs 2023 (€ 823,065) Favourable step	€ 913,688 Total debts 2025: € 913,688 ▲ 64% vs 2024 (€ 558,067) Unfavourable step	▲ 64%
Cash	€ 1,352,382 Cash 2022: € 1,352,382 First fiscal year in the series	€ 126,567 Cash 2023: € 126,567 ▼ 91% vs 2022 (€ 1,352,382) Unfavourable step	€ 135,093 Cash 2024: € 135,093 ▲ 7% vs 2023 (€ 126,567) Favourable step	€ 158,407 Cash 2025: € 158,407 ▲ 17% vs 2024 (€ 135,093) Favourable step	▲ 17%
Retained profit	€ 3,381,538 Retained profit 2022: € 3,381,538 First fiscal year in the series	€ 3,454,614 Retained profit 2023: € 3,454,614 ▲ 2% vs 2022 (€ 3,381,538) Favourable step	€ 3,743,994 Retained profit 2024: € 3,743,994 ▲ 8% vs 2023 (€ 3,454,614) Favourable step	€ 3,623,956 Retained profit 2025: € 3,623,956 ▼ 3% vs 2024 (€ 3,743,994) Unfavourable step	▼ 3%
Dividend	€ 426,996 Dividend 2022: € 426,996 First fiscal year in the series	€ 690,389 Dividend 2023: € 690,389 ▲ 62% vs 2022 (€ 426,996) Unchanged	€ 447,043 Dividend 2024: € 447,043 ▼ 35% vs 2023 (€ 690,389) Unchanged	€ 750,551 Dividend 2025: € 750,551 ▲ 68% vs 2024 (€ 447,043) Unchanged	▲ 68%
Balance sheet total	€ 4,018,590 Balance sheet total 2022: € 4,018,590 First fiscal year in the series	€ 4,297,679 Balance sheet total 2023: € 4,297,679 ▲ 7% vs 2022 (€ 4,018,590) Unchanged	€ 4,322,061 Balance sheet total 2024: € 4,322,061 ▲ 1% vs 2023 (€ 4,297,679) Unchanged	€ 4,557,644 Balance sheet total 2025: € 4,557,644 ▲ 5% vs 2024 (€ 4,322,061) Unchanged	▲ 5%

Key figures of A&E, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to A&E?

What happened at A&E in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 22, 2026 New annual accounts for financial year 2025: profit of € 630,513 (▼ 14% vs 2024). Source: NBB ↗
2019 MICHELINE HEYLEN became a director. NBB
2003 RENÉ HEYLEN became a director. NBB
Jan 18, 2003 New establishment in Genk. KBO
Apr 3, 1990 Start of the company according to the CBE. KBO

In short

From € 742,332 profit in 2022 to € 630,513 profit in 2025.

Paid € 1.4 million in corporate taxes since 2022.

Best year ever: 2023, with € 763,465 profit.

Paid out € 2.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

RENÉ HEYLEN MICHELINE HEYLEN

LINDE PROJECTS

Mithridate

A&E

Behind A&E are RENÉ HEYLEN and MICHELINE HEYLEN. RENÉ HEYLEN is also behind LINDE PROJECTS and Mithridate.

Directors

According to the 2025 annual accounts

RENÉ HEYLEN

Director

Also active at: LINDE PROJECTS, Mithridate

since 2003

MICHELINE HEYLEN

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Weg naar As 155

3600 Genk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0440.535.396
VAT number: BE 0440.535.396
Registered office: Weg naar As 155, 3600 Genk
Names & denominations: A&E
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 April 1990
Peppol: Active · Active since 29 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

A&E